EMT inhibitor-1

Research use only, not for human use.

EMT inhibitor -1 is an inhibitor of Hippo, Wnt signaling and TGF- macrophages (TGF-) with antitumor activity.

EMT inhibitor -1 is an inhibitor of Hippo, Wnt signaling and TGF- macrophages (TGF-) with antitumor activity.(In Vitro):EMT inhibitor-1 (C19) inhibiting cancer cell migration, proliferation, and resistance to doxorubicin in vitro.EMT inhibitor-1 (C19) (0-10μM; 24 hours) is an inhibitor of of Hippo, TGF-β, and Wnt signaling pathways with antitumor activities.(In Vivo):EMT inhibitor-1 (C19) (intraperitoneal injection; 5-20 mg/kg) exerts strong antitumor activity in a mouse tumor model. Mechanistically, EMT inhibitor-1 induces GSK3-β–mediated degradation of the Hippo transducer TAZ, through activation of the Hippo kinases Mst/Lats and the tumor suppressor kinase AMPK upstream of the degradation complex.C19 is dissolved in the vehicle solution (100 μL of DMEM containing 5% dimethyl sulfoxide).

——

——

——

Wnt/Notch/Hedgehog

Wnt/beta/catenin

PDE4| PDE5

——

——

1638526-21-2

319.2

C12H12Cl2N2O2S

>98% (HPLC)

In Vitro:?DMSO : 100 mg/mL (313.27 mM)

OCCCCOc1nsnc1-c1ccc(Cl)c(Cl)c1

——

(-20℃)

With Ice Pack

≥ 2 years